Deibel Bioscience Rebrands, Achieves ISO 17025 Accreditation {$excerpt:n} On June 19, Charles Deibel, president and CEO of Deibel Bioscience, announced two important changes to his cannabis testing laboratory: First, they changed their name from Deibel Laboratories to Deibel Bioscience. Secondly, they achieved ISO/IEC 17025:2017 accreditation. Deibel Labs is an internationally recognized corporation of 15 testing…
Cannabinoid Research & Pharmacology: A Q&A with Dr. Linda Klumpers {$excerpt:n} Dr. Linda Klumpers has a Ph.D. in clinical pharmacology of cannabinoids. Originally from the Netherlands, she began much of her career in studying cannabis there. She now lives and works in the United States, where she has worked on a number of projects, started…
Communications in Cannabis: The Playbook for Branding Success {$excerpt:n} Public relations has a role to play in every industry, providing value for companies looking to promote their services, announce a recent fund raise or want to plant a flag in their domain as a leader or subject matter expert. Some industries, however, are writing a…
Exploring growth in the European medical cannabis market {$excerpt:n} Luc Springinsfeld of leading investment bank Bryan, Garnier & Co explores the European medical cannabis market and the rise of medical cannabis investment in Europe. Since the beginning of 2019, there have been a dozen mergers and acquisitions or private placement deals with values above…
A Dank Opportunity: Private Equity in the Cannabis Industry & Compliance with the Securities Act {$excerpt:n} Under current federal law, financial institutions are extremely limited in the services and resources that they can offer to cannabis companies. Without access to traditional financing, cannabis companies have been forced to turn to outside investments to finance their…
Cannabis Contracting: The Potential Invalidity Defense Created By Federal Prohibition {$excerpt:n} The overwhelming majority of Americans now live in a state where cannabis is legal at the state level for at least some purposes.1 However, cannabis (excluding hemp) remains criminal under federal law for all purposes. This conflict between state and federal law presents challenges for…
Why Employee Training is Your Key to Financial Success {$excerpt:n} So, there you are, pondering your finances, there are many expenses and costs that go into running your business and when your budget is already tight, should you add or increase training to the expense list? Why frustrate yourself, looking for ways to train people, when…
Will Australia’s Cannabis Program Follow Canada’s Lead? {$excerpt:n} The news is intriguing in a world overwhelmed with pandemic news. THC Global, a Canadian-Aussie company now raising money and signing global deals, has just bought a “clinic network” of 30 prescribing physicians that will be able to supply up to 6,000 Australian patients this year. In…
COVID-19 & The Hypocrisy of Essential Cannabis Business {$excerpt:n} The cannabis industry is fraught with hypocrisy. Cannabis is good medicine as has been established by the numerous patients we have seen who are now off of their opioids, benzos and sleep agents due to the addition of medical cannabis products to their regimen. We see…
Basking in Sunshine: GrowHealthy {$excerpt:n} The Brand Marketing Byte showcases highlights from Pioneer Intelligence’s Cannabis Brand Marketing Snapshots, featuring data-led case studies covering marketing and business development activities of U.S. licensed cannabis companies. Here is a data-led, shallow dive on GrowHealthy: GrowHealthy – Basking in Sunshine Although Florida may only have a medical market and…
